NCT02982083View on ClinicalTrials.gov

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

September 30, 2020

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Raloxifene hydrochloride

20 patients consume raloxifene hydrochloride oral tablet daily for one year.

DRUG

Placebo Oral Tablet

20 patients consume placebo oral tablets daily for one year.

All Listed Sponsors
lead

Sara Saeidi Shahri

OTHER

NCT02982083 - Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter